Nosocomial E. coli Urine Isolates 1991 - 2009. Nosocomial K. pneumoniae Urine Isolates 1994 - 2009.

Slides:

Advertisements

Similar presentations

TREATMENT FOR SUPERIMPOSED PSEUDOMONAS AERUGINOSA INFECTION.

Advertisements

Edward L. Goodman, MD Core Faculty Hospital Epidemiologist June 27, 2013.

Multidrug Resistant Bacteria P. Stogsdill, MD, FIDSA Sept 2013.

Emerging Antimicrobial Resistance in Texas The new ESBLs.

2009 CLSI M100-S19 Update Nebraska Public Health Laboratory.

Enoch Omonge University of Nairobi

Welcome to the CDS Workshop Jeanette Pham Syd Bell Hobart 2011.

Plasmid mediated Metallo-Beta- Lactamase (MBL) Plasmid mediated Hydrolyses all beta-lactam (except aztreonam) Inhibited by EDTA Binds zinc (Zn 2+ ) Pseudomonas.

Sorting Out Antibiotics: A systematic approach to antibiotic selection Kenneth Alexander, M.D., Ph.D. Associate Professor of Pediatrics and Microbiology.

Clinical Case Study 2: How to deal with an ESBL

Resistance to  -lactam antibiotics within the Enterobacteriaceae Paul D. Fey, Ph. D. University of Nebraska Medical Center.

Warren S. Joseph, DPM, FIDSA Roxborough Memorial Hospital, Phila., PA

MDR Organisms in Holy Family Hospital Rawalpindi

Introduction to Antimicrobial Resistance and Antibiotic Stewardship

DHS/PP Antimicrobial Therapy David H. Spach, MD Professor of Medicine Division of Infectious Diseases University of Washington, Seattle.

Resistant Gram-Negative Bacilli ESBLs and Other Bad Bugs David P. Dooley, FACP UTHSC-San Antonio Audie Murphy VA Hospital San Antonio, TX.

JT Kirby, DJ Biedenbach, RN Jones, SENTRY Participants Group Univ of Iowa, Iowa City, IA; The JONES Group/JMI Laboratories, North Liberty, IA Poster #

Zunilda Djanun*, Rudyanto S**, Yulia Rosa***, *Dept. Clinical Pharmacology FMUI/CMH, **ICU CMH, *** Dept. Clinical Microbiology FMUI.

8th ISAP Symposium Can PK/PD be used in everyday clinical practice? Francesco Scaglione Department of Pharmacology, Toxicology and Chemotherapy, University.

Antimicrobial Resistance patterns among nosocomial gram negative bacilli by E-test and disc diffusion methods in Sina and Imam Hospital.

Listing Antimicrobial Resistant Pathogens of Public Health Importance Implications for Drug Development Listing Antimicrobial Resistant Pathogens of Public.

Figure 1 shows the 10 most frequently isolated blood pathogens in these hospitals from 1997 through These species represent about 85% of blood isolates.

Antibiotics 101 A review of common infections and their treatment For others, like me, who have a mental block against all things related to antibiotics.

Impetigo The best topical agent is mupirocin; other agents, such as bacitracin and neomycin, are less effective. Patients who have numerous lesions or.

Nosocomial E. coli Urine Isolates 1991 – Nosocomial K. pneumoniae Urine Isolates

4 th Lecture By Abdelkader Ashour, Ph.D. Phone: DENS 521 Clinical Dental Therapeutics.

UNCLASSIFIED LTC John M. Scherer/(301) 1 March 2010 Genesis of Clinical Microbiology in the CSH - Afghanistan 2002 LTC.

EARS-Net data on Antimicrobial Resistance in Ireland, Q3 2015

Impetigo Mupirocin; (bacitracin and neomycin, are less effective.) numerous lesions or not responding to topical agents: oral antimicrobials effective.

Dr. Laila M. Matalqah Ph.D. Pharmacology

Guideline for the Diagnosis and Management of Adults in LTC with Urinary Tract Infection (Part 2) This is intended as a guide for evidence-based decision-making.

Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.

(Ambler class A, Bush group 2) Inhibited by CA

Using Nursing Home Antibiograms To Improve Antibiotic Prescribing and Delivery Training Slides for Nursing Home Nurses Comprehensive Antibiogram Toolkit.

MRSA, ESBLs and Carbapenem Resistance

HAP and VAP Guidelines Update

Antimicrobial susceptibility of uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: a multicentre study in 2002 Seung-Ju.

Antimicrobial Resistance at GLA

Figure 1. Rate of antimicrobial resistance in S. pneumoniae

Figure 1. Percentage of Penicillin Non-Susceptible S

D. Sauerwein International Journal of Antimicrobial Agents

Bone and Joint Infections Tutoring

International Journal of Infectious Diseases

The Role of the Microbiology Laboratory in AMS programs

Average susceptibility

Antimicrobial Spectrum of Activity Visual Learning Exercises (“Flower Diagrams”) This work is licensed under the Creative Commons Attribution-NonCommercial-

Cell wall inhibitor Cephalosporins Dr. Naza M. Ali Lec D

Antibiotics sensitivity of microorganism causing nosocomial infections

Introduction to Antimicrobial Stewardship: Bugs and Drugs

C th Interscience Conference on Antimicrobial Agents and Chemotherapy October 25-28, Washington, DC Examining Temocillin Activity in Combination.

Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia.

19/ژانويه/17

A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals M. Nagao Clinical Microbiology and.

The need for new antibiotics

…monitoring trends in antimicrobial resistance in Canada

Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.

Percentage of Penicillin Non-Susceptible S

Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region K.B. Laupland, D.B. Gregson, D.L. Church,

Figure 1. Percentage of Penicillin Non-Susceptible S

Evolving problems with resistant pathogens

C. Gagliotti, L. Nobilio, M.L. Moro

Transferable plasmid mediating resistance to multiple antimicrobial agents in Klebsiella pneumoniae isolates in Greece I. Galani, E. Xirouchaki, K. Kanellakopoulou,

…monitoring trends in antimicrobial resistance in Canada

Scottish One Health Antimicrobial Use and Resistance in 2017 Annual Report

Profile of Pseudomonas aeruginosa resistance by country and antibiotic

…monitoring trends in antimicrobial resistance in Canada

…monitoring trends in antimicrobial resistance in Canada

…monitoring trends in antimicrobial resistance in Canada

G. Kahlmeter Clinical Microbiology and Infection

High prevalence of mutators among Enterobacter cloacae nosocomial isolates and their association with antimicrobial resistance and repetitive detection

Presentation transcript:

Nosocomial E. coli Urine Isolates

Nosocomial K. pneumoniae Urine Isolates

Nosocomial P. aeruginosa Urine Isolates Cefepime substituted for ceftazidime as of 2004

Nosocomial E. coli Non - Urine Isolates

Nosocomial K. pneumoniae Non - Urine Isolates

Nosocomial P. aeruginosa Non - Urine Isolates: Cefepime substituted for ceftazidime as of 2004

All Nosocomial Urine Isolates Cefepime substituted for ceftazidime as of 2004 Ceftriaxone, Ertapenem & TMP/SMX data exclude P. aeruginosa

All Nosocomial Non - Urine Isolates Cefepime substituted for ceftazidime as of 2004 Ceftriaxone, Ertapenem & TMP/SMX data exclude P. aeruginosa

Nosocomial vs. Outpatient Antimicrobial Resistance (2009) Ceftriaxone & TMP/SMX data exclude P. aeruginosa

GNR Antimicrobial Resistance Nosocomial Isolates - GLA 2009 Ceftriaxone, Ertapenem & TMP/SMX data exclude P. aeruginosa

S. aureus: Outpatient Resistance